Detalles de la búsqueda
1.
SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-513090
2.
Adenovirus-Vectored SARS-CoV-2 Vaccine Expressing S1-N Fusion Protein
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-491179
3.
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20113373
4.
Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In Covid-19 Patients Semiquantitatively.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-105445
5.
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20155978
6.
SARS-CoV-2 vaccine breakthrough infections are asymptomatic or mildly symptomatic and are infrequently transmitted.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259500
7.
Neutrophil extracellular traps induce the epithelial-mesenchymal transition: implications in post-COVID-19 fibrosis
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-374769
8.
Immunity to SARS-CoV-2 up to 15 months after infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-463699
9.
Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-371617
10.
Bispecific antibody prevents SARS-CoV-2 escape and protects mice from disease
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427567
Resultados
1 -
10
de 10
1
Próxima >
>>